Richard Pops, chief executive  of Alkermes.  Photograph: Aidan Crawley/The Irish Times

Irish drugmaker Alkermes fell Tuesday after receiving US regulatory approval for a schizophrenia treatment, and an analyst predicted that uptake of th(...)

Addyi, the drug, is likely to go on sale next month Photograph: EPA

Addyi, the pill for women with low libido, was approved by the Food and Drug Administration last month even though at least three FDA reviewers recomm(...)

The drug could cost women as much as $400 per month

Valeant Pharmaceuticals agreed to pay about $1 billion (€895 million) in cash for Sprout Pharmaceuticals, the US pharmaceutical group that this week r(...)

The drug flibanserin, which is marketed under the trade name Addyi, nicknamed “female Viagra”.

It has been dubbed the “female Viagra” and this week it became the first drug for treating loss of libido in women to win approval in the US. The deci(...)

The drug flibanserin, under the trade name Addyi, nicknamed “female Viagra” is shown in this undated Sprout Pharmaceuticals handout photograph released on Tuesday. Photograph: Sprout Pharmaceuticals/Reuters. 1:19

The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous l(...)

 The financial district of Pudong in Shanghai: officials from the city travelled to Ireland as part of China’s Senior Officials Training Programme. Photograph: Johannes Eisele/AFP/Getty Images

The current crackdown on extravagance and corruption has made overseas travel for government officials in China a lot more difficult than it used to b(...)

Eli Lilly’s plant in Cork . US regulator is concerned over experimental lung cancer drug.

Eli Lilly ’s experimental lung cancer drug raised concerns with US regulators that it may increase patients’ risk of suffering potentially deadly blo(...)

Janet Woodcock, FDA director of the agency’s Center for Drug Evaluation and Research: Amarin has taken a pre-emptive First Amendment case, accusing the FDA of restricting its right to free speech

The US Food and Drug Administration seems mildly discomfited. It’s not a state that one usually associates with the most powerful regulator of the pha(...)

Sprout Pharmaceuticals hopes its drug, flibanserin, will mirror the success of Pfizer’s erectile dysfunction drug Viagra. Photographer: JB Reed/Bloomberg News

A US federal advisory panel recommended approval of what would become the first drug to treat a lack of sexual desire in women after an intense lobbyi(...)

MedColl founder Roz Martin, who says the company is supplying approximately 250 pharmacies across Dubai, Abu Dhabi and other cities in the UAE

Irish biotechnology company MedColl has secured a €5 million contract to supply its anti-ageing and skincare supplements into pharmacy chains across t(...)